369 related articles for article (PubMed ID: 25303986)
1. Severe exacerbation of psychosis after sudden withdrawal of chlorpromazine in the treatment of methamphetamine-associated psychosis with aripiprazole and chlorpromazine: 2 case reports.
Wang G; Devi Thakoor JP; Wang X; Hao W
J Addict Med; 2014; 8(6):479-81. PubMed ID: 25303986
[TBL] [Abstract][Full Text] [Related]
2. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
Sulaiman AH; Gill JS; Said MA; Zainal NZ; Hussein HM; Guan NC
Int J Psychiatry Clin Pract; 2013 Jun; 17(2):131-8. PubMed ID: 22486597
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Adan-Manes J; Garcia-Parajua P
J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.
Farnia V; Shakeri J; Tatari F; Juibari TA; Yazdchi K; Bajoghli H; Brand S; Abdoli N; Aghaei A
Am J Drug Alcohol Abuse; 2014 Jan; 40(1):10-5. PubMed ID: 24359506
[TBL] [Abstract][Full Text] [Related]
8. Supersensitivity psychosis after tapering aripiprazole: a case report.
Chang CC; Hsu WY; Chen SH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):388-9. PubMed ID: 19166895
[No Abstract] [Full Text] [Related]
9. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
10. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
[TBL] [Abstract][Full Text] [Related]
11. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
[TBL] [Abstract][Full Text] [Related]
12. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
[TBL] [Abstract][Full Text] [Related]
13. Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
Edlinger M; Seppi K; Fleischhacker W; Hofer A
Int Clin Psychopharmacol; 2013 Jul; 28(4):214-6. PubMed ID: 23652781
[TBL] [Abstract][Full Text] [Related]
14. The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosis.
Park JI; Cho DH; Hahn SW; Jeong B; Kim JH; Kim SW; Koo MS; Lee SH; Lee SJ; Lee YH; Park JI; Rho SH; Chung YC
Int Clin Psychopharmacol; 2014 Mar; 29(2):77-85. PubMed ID: 23970176
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole possibly worsens psychosis.
Ramaswamy S; Vijay D; William M; Sattar SP; Praveen F; Petty F
Int Clin Psychopharmacol; 2004 Jan; 19(1):45-8. PubMed ID: 15101571
[TBL] [Abstract][Full Text] [Related]
16. [Aripiprazole: a new atypical antipsychotic drug].
Fischer B; Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole treatment for psychosis associated with Friedreich's ataxia.
Chan YC
Gen Hosp Psychiatry; 2005; 27(5):372. PubMed ID: 16168800
[No Abstract] [Full Text] [Related]
18. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.
Josiassen RC; Shaughnessy RA; Filymer DM; Donohue AM; Kacso M; Finkel N; Curtis J; Audino B; Skuban N
Early Interv Psychiatry; 2010 Feb; 4(1):57-63. PubMed ID: 20199481
[TBL] [Abstract][Full Text] [Related]
19. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.
Broekhof R; Gosselink MJ; Pijl H; Giltay EJ
Gen Hosp Psychiatry; 2012; 34(2):209.e1-3. PubMed ID: 21872335
[TBL] [Abstract][Full Text] [Related]
20. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
Raja M; Azzoni A
Psychiatr Danub; 2008 Sep; 20(3):323-8. PubMed ID: 18827757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
